首页> 外文OA文献 >Post-stent management with a pneumatic groin compression device and self injected low molecular weight heparin.
【2h】

Post-stent management with a pneumatic groin compression device and self injected low molecular weight heparin.

机译:支架后管理采用气动腹股沟压缩装置和自注射低分子量肝素。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: The benefits of intracoronary stent implantation are offset by an increased risk of complications at the arterial puncture site and a prolonged hospital stay. Much of this morbidity can be attributed to the generally perceived need to achieve systemic anticoagulation after stent implantation. AIM: To test a simplified protocol for post-stent management using the Femostop pneumatic groin compression device and low molecular weight (fractionated) heparin (LMWH) administered by subcutaneous injection. PATIENTS: A case series of 100 consecutive patients, with stable angina pectoris, undergoing coronary stenting for a suboptimal result after conventional balloon angioplasty. METHODS: All patients were managed with a new post-stent protocol using the Femostop pneumatic groin compression device and LMWH. The incidence of complications and the length of hospital stay were recorded. RESULTS: The clinical course was uncomplicated in 92 patients and their discharge from hospital was achieved on the first post-procedural day for 44 patients and on the second for the remaining 48. The rate of vascular or bleeding complications was 6%. CONCLUSIONS: LMWH administered by subcutaneous injection may provide a practical and effective alternative to the use of intravenous heparin when systemic anticoagulation is used after stent implantation.
机译:背景:冠状动脉内支架植入的好处被动脉穿刺部位并发症风险的增加和住院时间的延长所抵消。这种发病率的大部分可以归因于普遍认为的在支架植入后实现全身抗凝的需求。目的:使用Femostop气动腹股沟加压装置和皮下注射低分子量肝素(LMWH),测试简化的支架后管理方案。患者:连续100例患有稳定型心绞痛的患者,在常规球囊血管成形术后接受冠状动脉支架置入术,结果欠佳。方法:所有患者均采用Femostop气动腹股沟加压装置和LMWH进行新的支架后方案治疗。记录并发症的发生率和住院时间。结果:92例患者的临床过程不复杂,在手术后的第一天有44例患者出院,其余48例在第二天出院。血管或出血并发症的发生率为6%。结论:当支架植入后进行全身抗凝治疗时,皮下注射LMWH可替代静脉肝素,提供一种实用有效的替代方法。

著录项

  • 作者

    Stables, R. H.; Sigwart, U.;

  • 作者单位
  • 年度 1996
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号